Comparison of autogeneic and allogeneic natural killer cells immunotherapy on the clinical outcome of recurrent breast cancer

In the present study, we aimed to compare the clinical outcome of autogeneic and allogeneic natural killer (NK) cells immunotherapy for the treatment of recurrent breast cancer. Between July 2016 and February 2017, 36 patients who met the enrollment criteria were randomly assigned to two groups: aut...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Shuzhen, Xu, Kecheng, Niu, Lizhi, Wang, Xiaohua, Liang, Yingqing, Zhang, Mingjie, Chen, Jibing, Lin, Mao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584889/
https://www.ncbi.nlm.nih.gov/pubmed/28894383
http://dx.doi.org/10.2147/OTT.S139986

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584889/
https://www.ncbi.nlm.nih.gov/pubmed/28894383
http://dx.doi.org/10.2147/OTT.S139986

Ejemplares similares